Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study.

导出 OA

翻译打印收藏纠错

第一作者： Jongmin,Lee

第一单位： Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, The Catholic University of Korea, Seoul 06591, Korea.

作者： Jongmin,Lee ^[1] ; Sung-Soo,Park ^[2] ; Tong Yoon,Kim ^[2] ; Dong-Gun,Lee ^[3] ; Dong-Wook,Kim ^[2]

作者单位： Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[1] Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[2] Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[3] Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. ^[4]

关键词 COVID-19 SARS-CoV-2 lymphopenia mortality prediction

DOI 10.3390/cancers13030471

PMID 33530509

发布时间 2021-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交